Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Robert Bulten

Developmental - Behavioral Pediatrics Wyoming, MI Medical Doctor

NPI 1023177268 CMS profile 227366

4340 Burlingame Ave Sw, Wyoming, MI 49509

Open in the dashboard

General payments

$3,103

218 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Robert Bulten of Wyoming, MI is reported in the CMS Open Payments database as having received $3,103 across 218 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Developmental - Behavioral Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $170 9
2022 General $664 56
2021 General $1,108 72
2020 General $759 51
2019 General $402 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Bulten
  • Developmental - Behavioral Pediatrics median
  • Middle half of Developmental - Behavioral Pediatrics
  • National median

In program year 2025, general payments to Robert Bulten were reported at $0. Among 160 Developmental - Behavioral Pediatrics profiles paid that year, the median was $77 and the middle half received between $27 and $211.

Show as a table
Year Robert Bulten Developmental - Behavioral Pediatrics median Middle half National median
2019 $402 $106 $28–$315 $163
2020 $759 $55 $19–$181 $114
2021 $1,108 $96 $25–$343 $132
2022 $664 $86 $23–$235 $149
2023 $170 $71 $25–$348 $160
2024 $0 $74 $25–$237 $164
2025 $0 $77 $27–$211 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Ironshore Pharmaceuticals Inc. $1,094 88 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $791 44 payments
  3. Supernus Pharmaceuticals, Inc. $376 34 payments
  4. Lundbeck LLC $246 15 payments
  5. Jazz Pharmaceuticals Inc. $179 10 payments
  6. Tris Pharma Inc $177 11 payments
  7. Neos Therapeutics, LP $81 6 payments
  8. Vertical Pharmaceuticals, LLC $45 3 payments
  9. Allergan Inc. $30 1 payment
  10. Shire North American Group Inc $25 2 payments
  11. Other $59 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $3,066 216 payments
  2. Education $37 2 payments
Products named General payments · program years 2019–2023
  1. JORNAY PM Central Nervous Stimulant ADHD $926 78 payments
  2. VYVANSE $421 21 payments
  3. QELBREE $376 34 payments
  4. TRINTELLIX $346 19 payments
  5. SUNOSI $179 10 payments
  6. REXULTI $173 10 payments
  7. Jornay PM 20mg capsules (Bottle of 100) $91 6 payments
  8. Adzenys XR-ODT $81 6 payments
  9. COTEMPLA XR-ODT $81 6 payments
  10. JORNAY PM Central Nervous System Stimulant $76 4 payments
  11. Other $433 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

218 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Developmental - Behavioral Pediatrics in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record